Raymond James Financial’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5M Buy
364,642
+8,313
+2% +$128K ﹤0.01% 2737
2026
Q2
$5.68M Buy
356,329
+17,799
+5% +$273K ﹤0.01% 2633
2026
Q1
$4.78M Buy
338,530
+4,088
+1% +$60.2K ﹤0.01% 2623
2025
Q4
$4.74M Sell
334,442
-133,005
-28% -$1.92M ﹤0.01% 2559
2025
Q3
$6.91M Buy
467,447
+93,659
+25% +$1.4M ﹤0.01% 2214
2025
Q2
$5.66M Buy
373,788
+91,285
+32% +$1.33M ﹤0.01% 2288
2025
Q1
$4.07M Buy
282,503
+73,872
+35% +$1.13M ﹤0.01% 2466
2024
Q4
$3.16M Buy
+208,631
New +$3.35M ﹤0.01% 2631

Other funds holding BCAT

Raymond James Financial's BCAT Position: Q3 2026 in Review

Raymond James Financial increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 2.3% in Q3 2026, buying an estimated $128K and bringing the position to 364,642 shares worth $5M. The position accounts for ﹤0.01% of the portfolio, ranked #2737.

Raymond James Financial first reported a position in BCAT in Q4 2024 and has held it in 8 quarters since. The position peaked at $6.91M in Q3 2025. 69 funds tracked by Wall St. Rank hold BCAT as of Q3 2026.

  • Raymond James Financial held 364,642 shares of BlackRock Capital Allocation Term Trust worth $5M as of Q3 2026.
  • Raymond James Financial bought 8,313 BlackRock Capital Allocation Term Trust shares in Q3 2026, an estimated $128K.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #2737 holding.
  • Raymond James Financial first reported a position in BlackRock Capital Allocation Term Trust in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's BlackRock Capital Allocation Term Trust position peaked at $6.91M in Q3 2025.
  • 69 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.